Candriam SCA’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26,323
Closed -$1.42M 867
2023
Q1
$1.42M Sell
26,323
-1
-0% -$57 0.01% 639
2022
Q4
$1.49M Sell
26,324
-6,083
-19% -$326K 0.01% 626
2022
Q3
$1.6M Buy
32,407
+1,824
+6% +$95.3K 0.01% 626
2022
Q2
$1.58M Sell
30,583
-6,123
-17% -$312K 0.01% 551
2022
Q1
$1.88M Buy
36,706
+10,582
+41% +$589K 0.01% 554
2021
Q4
$1.58M Hold
26,124
0.01% 596
2021
Q3
$1.59M Sell
26,124
-29,595
-53% -$1.89M 0.01% 620
2021
Q2
$3.67M Buy
55,719
+14,802
+36% +$984K 0.03% 465
2021
Q1
$2.67M Buy
40,917
+29
+0.1% +$1.85K 0.02% 473
2020
Q4
$2.78M Buy
+40,888
New +$2.77M 0.02% 484

Other funds holding UL

Candriam SCA's UL Position: Q2 2023 in Review

Candriam SCA sold out of Unilever (UL) in Q2 2023, closing a stake of 26,323 shares — an estimated $1.42M sold.

Candriam SCA first reported a position in UL in Q4 2020 and held it in 10 quarters. The position peaked at $3.67M in Q2 2021. 1,083 funds tracked by Wall St. Rank hold UL as of Q2 2023.

  • Candriam SCA reported no remaining Unilever position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 26,323 Unilever shares in Q2 2023, an estimated $1.42M.
  • Candriam SCA first reported a position in Unilever in Q4 2020 and held it in 10 quarters.
  • Candriam SCA's Unilever position peaked at $3.67M in Q2 2021.
  • 1,083 funds tracked by Wall St. Rank held Unilever as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.